Article
Humana's Roy A. Beveridge, MD, to Give Keynote at Patient-Centered Oncology Care
With value-based reimbursement now far from its infancy, the chief medical officer for Humana will forecast what’s ahead in payment reform-and how oncology connects with what is happening in primary care, hospitals, and the pharmaceutical industry. Roy A. Beveridge, MD, will open Patient-Centered Oncology Care, which will meet November 17-18, 2016, in Baltimore, Maryland.
PLAINSBORO, N.J.—Roy A. Beveridge, MD, senior vice president and chief medical officer for Humana Inc., will give the keynote address November 17, 2016, at Patient-Centered Oncology Care (PCOC), to be held in Baltimore, Maryland.
The address, “How Value-Based Care May Affect Oncology,” will take place during the opening session of the conference, which meets November 17-18 at the Renaissance Baltimore Harborplace Hotel. For information and to register, click here. PCOC is presented by The American Journal of Managed Care.
Dr. Beveridge joined Humana in May 2013 from McKesson Specialty Health, where he was chief medical officer for McKesson Specialty Health after it acquired US Oncology; Dr. Beveridge had been US Oncology’s executive vice president and medical director. A medical oncologist who practiced for more than 20 years, Beveridge has described Humana’s transformation from a traditional insurer to a “health company,” with a focus on engaging physicians to improve quality.
Humana is a leader in Medicare Advantage, and its members account for approximately 3.2 million of the 18.5 million beneficiaries in the program. Just this week, Humana announced that its enrollees in the value-based Medicare Advantage program saved 20% over those in traditional fee-for-service Medicare programs.
Last year, Dr. Beveridge was among the leaders whose commentary on health system transformation appeared in The American Journal of Managed Care during its 20th anniversary celebration. His essay, “The Path to Value Through the Use of Holistic Care,” discussed the need for health system engage consumers more fully and to identify gaps in care, through the use of data and better patient-physician communication.
Patient-Centered Oncology Care, now in its fifth year, will bring together stakeholders from across the oncology care spectrum, including payers, providers, policy leaders, quality measurement experts, and pharmacy benefit managers.
The conference chair, Joseph Alvarnas, MD, a hematologist/oncologist and director of Value-Based Analytics for City of Hope, welcomed Dr. Beveridge’s participation at PCOC.
“In his leadership role as the chief medical officer for Humana, Dr. Beveridge has an amazing, global understanding of the rapidly evolution from fee for service toward payment for value delivery. As the former chief medical officer for McKesson Specialty Health, he also understands the intricacies of delivering cancer care in this era of precision-based cancer care.
“Dr. Beveridge’s ability to understand the tension between these paradigms and the systemic ways in which we can balance the priorities of precision medicine and population health will lend an essential perspective to this conference and enable some ‘game changing’ conversations around these issues,” Dr. Alvarnas said.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
Supplemental Dental, Vision Benefits May Not Justify MA Payments for VA-Covered Veterans
